false
OasisLMS
Login
Catalog
Kidney Week 2026 Early Program On-Demand - Critica ...
ARDS and ECMO: Managing Fluids and Kidney Support ...
ARDS and ECMO: Managing Fluids and Kidney Support Without Harming the Lungs
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Dr. Kathleen Liu discussed the challenges of managing acute respiratory distress syndrome (ARDS) alongside acute kidney injury (AKI), emphasizing the need to balance lung and kidney priorities. AKI affects roughly 25–40% of patients with ARDS and is associated with substantially higher mortality.<br /><br />For non-intubated ARDS, high-flow nasal oxygen is an important support strategy. Once shock has resolved, evidence from the FACTT trial supports conservative fluid management: it improved ventilator-free days and reduced dialysis use without a significant mortality benefit. Fluid status and creatinine should be interpreted together, since fluid accumulation can mask kidney injury and fluid removal can raise creatinine.<br /><br />For severe, refractory respiratory failure, venovenous ECMO may provide support while the lungs recover. AKI is common during ECMO, and continuous renal replacement therapy is often needed to control fluid overload as well as treat kidney failure. Teams must choose whether to integrate the renal replacement circuit with the ECMO circuit or run it separately, and manage risks such as bleeding, thrombosis, hemolysis, electrolyte disturbances, and circuit complications.<br /><br />The overall message was to coordinate respiratory, renal, and fluid management; avoid nephrotoxic “second hits”; individualize diuresis and ultrafiltration; and monitor for kidney recovery after critical illness.
Asset Caption
Kathleen D. Liu, MD, PhD, FASN
Meta Tag
Speaker
Kathleen D. Liu
Keywords
ARDS
acute kidney injury
ECMO
fluid management
continuous renal replacement therapy
high-flow nasal oxygen
nephrotoxicity
×
Please select your language
1
English